Lisata Therapeutics (LSTA)

• Market cap: $45.3M
• 1 day: -0.2%
• 5 days: -0.6%
• 1 month: 11.83%
• 3 months: 142.03%
• 6 months: 118.78%
• Year to date: 155.61%
• 1 year: 119.74%
• 5 years: -83.86%
• 10 years: -96.06%
• Sector: Healthcare
• Industry: Biotechnology

About: Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Employees: 26